BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9712465)

  • 1. A limited sampling strategy for the estimation of eight-hour neoral areas under the curve in renal transplantation.
    Meier-Kriesche HU; Kaplan B; Brannan P; Kahan BD; Portman RJ
    Ther Drug Monit; 1998 Aug; 20(4):401-7. PubMed ID: 9712465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A limited sampling strategy for the estimation of 12-hour SangCya and neoral AUCs in renal transplant recipients.
    Meier-Kriesche HU; Alloway R; Gaber AO; Canafax DM; Kaplan B
    J Clin Pharmacol; 1999 Feb; 39(2):166-71. PubMed ID: 11563409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A limited sampling strategy for the estimation of Neoral AUCs in pediatric patients.
    Meier-Kriesche HU; Bonilla-Felix MA; Ferris ME; Swinford R; Kahan BD; Brannan P; Portman RJ
    Pediatr Nephrol; 1999 Nov; 13(9):742-7. PubMed ID: 10603112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
    Canadian Neoral Renal Transplantation Study Group
    Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sandimmune to Neoral conversion and value of abbreviated AUC monitoring in stable pediatric kidney transplant recipients.
    Kelles A; Herman J; Tjandra-Maga TB; Van Damme-Lombaerts R
    Pediatr Transplant; 1999 Nov; 3(4):282-7. PubMed ID: 10562972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?
    Gaspari F; Perico N; Pisoni R; Anedda MF; Signorini O; Caruso R; Gotti E; Remuzzi G
    Clin Transplant; 1998 Oct; 12(5):379-90. PubMed ID: 9787945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of cyclosporine area under the curve using a three-point sampling strategy after Neoral administration.
    Gaspari F; Anedda MF; Signorini O; Remuzzi G; Perico N
    J Am Soc Nephrol; 1997 Apr; 8(4):647-52. PubMed ID: 10495795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine microemulsion (Neoral) absorption profiling and sparse-sample predictors during the first 3 months after renal transplantation.
    International Neoral Renal Transplantation Study Group.
    Am J Transplant; 2002 Feb; 2(2):148-56. PubMed ID: 12099517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited sampling model for area-under-the-curve monitoring in pediatric patients receiving either Sandimmune or Neoral cyclosporin A oral formulations.
    Medeiros M; Pérez-Urizar J; Muñoz R; Castañeda-Hernández G
    Pediatr Transplant; 1999 Aug; 3(3):225-30. PubMed ID: 10487284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A limited sampling strategy for the estimation of 12-hour Neoral systemic drug exposure in heart transplant recipients.
    Balram C; Sivathasan C; Cheung YB; Tan SB; Tan YS
    J Heart Lung Transplant; 2002 Sep; 21(9):1016-21. PubMed ID: 12231373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation].
    Roy A; Grant DR; Kneteman NM; Tchervenkov JI; Levy GA; Tan A; Hendricks L
    Ann Chir; 1998; 52(8):716-21. PubMed ID: 9846420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose adjustment strategy for oral microemulsion formulation of cyclosporine: population pharmacokinetics-based analysis in kidney transplant patients.
    Tokui K; Kimata T; Uchida K; Yuasa H; Hayashi Y; Itatsu T; Nabeshima T
    Ther Drug Monit; 2004 Jun; 26(3):287-94. PubMed ID: 15167630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abbreviated pharmacokinetic profiles in area-under-the-curve monitoring of cyclosporine therapy in de novo renal transplant patients treated with Sandimmune or Neoral. Neoral study group.
    Marsh CL
    Ther Drug Monit; 1999 Feb; 21(1):27-34. PubMed ID: 10051051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A limited sampling strategy for the estimation of 12-hour cyclosporine neoral area under the curve in Chinese cardiac transplant recipients.
    Wang CH; Ko WJ; Chou NK; Wang SS
    Transplant Proc; 2004 Oct; 36(8):2390-2. PubMed ID: 15561259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited sampling strategy for cyclosporine (Neoral) area under the curve monitoring in pediatric kidney transplant recipients.
    Strong DK; Lai A; Primmett D; White CT; Lirenman DS; Carter JE; Hurley RM; Virji M; Ensom MH
    Pediatr Transplant; 2005 Oct; 9(5):566-73. PubMed ID: 16176411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of pharmacokinetics of Neoral and Sandimmune in stable pediatric liver transplant recipients.
    van Mourik ID; Thomson M; Kelly DA
    Liver Transpl Surg; 1999 Mar; 5(2):107-11. PubMed ID: 10071349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abbreviated kinetic profiles in area-under-the-curve monitoring of cyclosporine therapy. Technical note.
    Gaspari F; Perico N; Signorini O; Caruso R; Remuzzi G
    Kidney Int; 1998 Dec; 54(6):2146-50. PubMed ID: 9853281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited sampling strategies for estimating intravenous and oral cyclosporine area under the curve in pediatric hematopoietic stem cell transplantation.
    Sarem S; Nekka F; Barrière O; Bittencourt H; Duval M; Teira P; Haddad E; Théorêt Y; Lapeyraque AL; Litalien C
    Ther Drug Monit; 2015 Apr; 37(2):198-205. PubMed ID: 25162214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A polycaprolactone nanoparticle formulation of cyclosporin-A improves the prediction of area under the curve using a limited sampling strategy.
    Molpeceres J; Chacón M; Guzmán M; Berges L; del Rosario Aberturas M
    Int J Pharm; 1999 Sep; 187(1):101-13. PubMed ID: 10502617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.